Oracle Corp
—- Market cap
- —
- Debt
- —
- Cash
- −$31.29B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ORCL stock price vs ROST: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ROST's multiple
Needs ROST P/E.
Implied fair value · at ORCL's multiple
Needs ORCL P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
12 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ORACLE CORP · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Ross Stores, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Microsoft Corporation
ORCL vs MSFT
Amazon.com, Inc.
ORCL vs AMZN
Alphabet Inc.
ORCL vs GOOGL
International Business Machines Corporation
ORCL vs IBM
Cisco Systems, Inc.
ORCL vs CSCO
Salesforce, Inc.
ORCL vs CRM
TJX COMPANIES INC /DE/
ORCL vs TJX
Walgreens Boots Alliance, Inc.
ORCL vs WBA
NORDSTROM INC
ORCL vs JWN
Macy's, Inc.
ORCL vs M
DILLARD'S, INC.
ORCL vs DDS
TARGET CORP
ORCL vs TGT
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ORCL can sustain its 17.3% revenue growth and 30.6% operating margin, then the stock looks attractive to own because it is priced below the top of its DCF range and well below ROST-implied price.
ORCL’s current price of $129.87 sits below the midpoint of its historical band and within the DCF range, while ROST-implied price of $221.44 suggests meaningful upside if the P/E framework is the right anchor. The valuation story is mixed because ORCL trades at a lower P/E than ROST but a higher P/S and much lower EV/EBITDA multiple, implying the market is already rewarding ORCL’s superior earnings quality.
Supporting Metrics